[2020]Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR_PI3K_mTOR signaling

上一条：[2020]Mechanisms of the lipopolysaccharide‑induced inflammatory__response in alveolar epithelial cell_macrophage co‑culture

下一条：[2020]Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases_ Recent Advances

【关闭】